These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30806610)

  • 1. Can YKL-40 be an Inflammatory Biomarker in Vitamin D Deficiency?
    Can U; Uysal S; Ruveyda Ugur A; Toker A; Aslan U; Taha Hidayetoglu B
    Int J Vitam Nutr Res; 2019 Nov; 89(5-6):309-313. PubMed ID: 30806610
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
    Pei Q; Sang WF; Zhao XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inflammatory marker in dialysis patients: YKL-40.
    Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
    Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.
    Conrozier T; Carlier MC; Mathieu P; Colson F; Debard AL; Richard S; Favret H; Bienvenu J; Vignon E
    Ann Rheum Dis; 2000 Oct; 59(10):828-31. PubMed ID: 11005786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
    Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
    Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients.
    Malyszko J; Koc-Zorawska E; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2651-3. PubMed ID: 25380887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
    Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
    Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
    Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.
    Hedegaard A; Ripa RS; Johansen JS; Jørgensen E; Kastrup J
    Scand J Clin Lab Invest; 2010 Apr; 70(2):80-6. PubMed ID: 20102300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
    Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
    J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease.
    Vind I; Johansen JS; Price PA; Munkholm P
    Scand J Gastroenterol; 2003 Jun; 38(6):599-605. PubMed ID: 12825867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome.
    Akboğa MK; Yalçın R; Şahinarslan A; Yılmaz Demirtaş C; Paşaoğlu H; Abacı A
    Anatol J Cardiol; 2016 Dec; 16(12):953-958. PubMed ID: 27443476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
    Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
    Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum YKL-40 is increased in patients with slow coronary flow.
    Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
    Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
    Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
    Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate vitamin D deficiency and inflammation related markers in overweight/obese schoolchildren.
    Rodríguez-Rodríguez E; Aparicio A; Andrés P; Ortega RM
    Int J Vitam Nutr Res; 2014; 84(1-2):98-107. PubMed ID: 25835240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients.
    Przybyłowski P; Janik L; Wasilewski G; Nowak E; Koźlik P; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2860-3. PubMed ID: 25380936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer.
    Rasmussen LS; Yilmaz MK; Falkmer UG; Poulsen LØ; Bøgsted M; Christensen HS; Bojesen SE; Jensen BV; Chen IM; Johansen AZ; Hansen CP; Hasselby JP; Holländer N; Nielsen SE; Andersen F; Bjerregaard JK; Pfeiffer P; Johansen JS
    Eur J Cancer; 2021 Feb; 144():72-80. PubMed ID: 33341448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.